Dr. James H. Finigan, MD

Dr. Finigan practices at National Jewish Health in Denver, Colorado, part of National Jewish Health.

Dr. Finigan's NPI, 1710029178, was assigned on February 13, 2007. Dr. Finigan graduated from University of Rochester School of Medicine and Dentistry in 1999. Dr. Finigan holds Colorado license 49476.

Dr. Finigan's primary practice is National Jewish Health, at 1400 Jackson St, Denver, CO 80206 in Denver County. The practice phone is (303) 388-4461.

Dr. Finigan's primary practice is National Jewish Health in Denver, Colorado, part of National Jewish Health. The medical group on file is National Jewish Health. Dr. Finigan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Finigan practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Finigan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Finigan is licensed in Colorado.

CMS data shows 53 Medicare services from Dr. Finigan across 1 procedure code in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $6,017 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Finigan in 2024. The largest group is 75 to 84, with 21 patients. 75% of them have copd, and 75% have high blood pressure. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Finigan's median patient age at 73, with 53% women.

In 2024, Dr. Finigan wrote 339 Medicare Part D claims for 53 patients. 32% of them were for generic drugs. CMS names the drug for 256 of them, across 11 drugs with 11 or more claims each, at $94,959 in total drug cost. In 2023, CMS named 227 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Finigan for performance year 2024, reported as part of a group. Dr. Finigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Finigan as offering telehealth.

Dmand AI links 16 papers to Dr. Finigan, published from 2011 to 2020. 2012 was the busiest year, with 2. The most frequent topics are Lung Neoplasms, Lung and ErbB Receptors. Dr. Finigan has published most often in Am J Respir Cell Mol Biol. Dr. Finigan's most frequent co-authors are Jeffrey A. Kern, MD, James D. Crapo, MD and Mohammad Shatat, MBBS.

CMS Open Payments shows 18 general payments to Dr. Finigan from 5 drug and device companies from 2018 to 2024. Consulting fees make up the largest share, 84% of the total. EMD Serono, Inc. paid the most, $23,829.

Dr. Finigan graduated from University of Rochester School of Medicine and Dentistry in 1999.